Techno Medica Co., Ltd.

2026/11/06 19:48 Updated
Market Cap: $89.5M (¥14.2B)
Stock Price: $13.42 (¥2,127)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Revision of Dividend Forecast (Dividend Increase)

Revised the annual dividend forecast for the fiscal year ending March 2027, raising the year-end dividend per share from the previous forecast of 93 yen to 97 yen. The company targets a dividend payout ratio of 80% or higher and revised the forecast taking into account the reduction in shares subject to dividends resulting from the share buyback. The company will continue to strengthen shareholder returns.

Importance:
Page Updated: November 7, 2026
IR Disclosure Date: November 6, 2026

Key Figures

  • Year-end dividend per share forecast: 97 yen
  • Previous forecast: 93 yen
  • Prior fiscal year actual: 129 yen (Fiscal year ended March 2026)

AI要約

Overview of Dividend Policy and Revision

At the Board of Directors meeting held today, we revised the dividend forecast for the fiscal year ending March 2027. We aim for a dividend payout ratio of 80% or higher and will promote strengthened shareholder returns throughout the medium-term plan period. Taking into account the share buyback and the resulting reduction in the number of shares subject to dividends, we raised the year-end dividend per share forecast from the previous forecast of 93 yen to 97 yen. Items that are unclear are indicated as "Unknown."

Future Shareholder Returns and Impact

Throughout the FY26 medium-term plan period, we will strengthen shareholder returns based on our cash allocation policy. This revision reflects the reduction in dividend-eligible shares following the execution of the share buyback and is positioned as a measure to enhance shareholder value. While considering future management conditions, we intend to maintain and improve the dividend payout ratio.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Techno Medica Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →